Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta|June 29, 2013
Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptidesShalini Singh, Praveen Papareddy, Martina Kalle, et al.Biomacromolecules|March 30, 2013
Lipopolysaccharide interactions of C-terminal peptides from human thrombinShalini Singh, Martina Kalle, Praveen Papareddy, et al.Biomaterials|April 20, 2015
Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptidesGopinath Kasetty, Martina Kalle, Matthias Mörgelin, et al.Biochimica Et Biophysica Acta|February 14, 2014
An antimicrobial helix A-derived peptide of heparin cofactor II blocks endotoxin responses in vivoPraveen Papareddy, Martina Kalle, Shalini Singh, et al.Plos Pathogens|December 17, 2013
The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsisPraveen Papareddy, Martina Kalle, Ole E Sørensen, et al.The Journal of Biological Chemistry|September 10, 2014
Antimicrobial effects of helix D-derived peptides of human antithrombin IIIPraveen Papareddy, Martina Kalle, Ravi K V Bhongir, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2013
Proteolytic activation transforms heparin cofactor II into a host defense moleculeMartina Kalle, Praveen Papareddy, Gopinath Kasetty, et al.Plos One|January 10, 2013
Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activityPraveen Papareddy, Martina Kalle, Ole E Sørensen, et al.The Journal of Antimicrobial Chemotherapy|October 28, 2015
NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infectionPraveen Papareddy, Gopinath Kasetty, Martina Kalle, et al.Antimicrobial Agents and Chemotherapy|March 16, 2011
Structure-activity studies and therapeutic potential of host defense peptides of human thrombinGopinath Kasetty, Praveen Papareddy, Martina Kalle, et al.Pageof 2